🇺🇸 ENANTA PHARMACEUTICALS INCENTA
Get ENANTA PHARMACEUTICALS INC filings on Telegram the moment they are published.
Follow ENANTA PHARMACEUTICALS INC on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 8.01
Overview: The Unified Patent Court ruled on October 29, 2026, that Enanta's '265 Patent is invalid, dismissing its infringement action against Pfizer Inc.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest